April 22, 2021
A key health ministry advisory panel on April 21 gave the thumbs-up for MSD’s antibiotic combining relebactam, imipenem, and cilastatin, known as Recarbrio overseas, putting it in line for approval as early as June. The Pharmaceutical Affairs and Food Sanitation...read more